The year 2000 is marked by the production of the sequence of the human genome. A 'working draft' of high quality sequence covering 90% of the genome has been determined and a quarter is in finished form, including the first two completed chromosomes. All sequence data from the project is made freely available to the community via the Internet, for further analysis and exploitation. The challenge which lies ahead is to decipher the information. Knowledge of the human genome sequence will enable us to understand how the genetic information determines the development, structure and function of the human body. We will be able to explore how variations within our DNA sequence cause disease, how they affect our interaction with our environment and ultimately to develop new and effective ways to improve human health.
THE IMPORTANCE OF SEQUENCING WHOLE GENOMES
The ability to undertake DNA sequencing on a large scale started a revolution in biology, as it became possible to determine the complete DNA sequence of any organism and therefore obtain a full description of genes and other important biological information stored in the genome. For the first time, it was possible to define the complete set of proteins required for a particular life form, to make full comparisons of protein sets between different species, to discover the basis of their similarities and differences and to explore the evolutionary relationship between them. For example, the 15 Mb genome sequence of baker's yeast Saccharomyces cerevisiae, completed in 1996, contains >6000 genes(1,2). These encode all the functions required for a eukaryotic cell. The 99 Mb genome sequence of the free-living soil nematode worm Caenorhabditis elegans, completed 2 years later, contains 19 000 genes (3) . This constitutes a complete gene set for a multicellular organism, encoding proteins involved in basic eukaryotic cell functions and also many others involved, for example, in development, cell-cell interactions, motility, feeding and reproduction. A recent cross comparison of the complete gene sets (4) has revealed that 23% of the proteins encoded by yeast genes have apparent homologues in the nematode worm, reflecting functions common to both organisms. A closer examination of matches between individual protein domains illustrates another level of homology, with 41% of yeast proteins matching at least one protein domain in a nematode protein and 36% being homologous to a representative mammalian protein set (4) . It is evident that diversity of function has arisen in evolution as a result of existing domains being used in new combinations, as well as from the generation of entirely new proteins.
These model genome projects used a strategy by which a physical map was constructed of overlapping bacterial or yeast artificial chromosome (YAC) clones representing the entire genomic DNA of the organism (5) (6) (7) . A minimum overlapping set of clones (the tile path) was then chosen for sequencing. Each clone was then subjected to complete sequencing, comprising an initial random shotgun phase followed by a phase of directed finishing, resulting in a final reference sequence with an accuracy of >99.99% (8) . Completion of these model genomes thus provided many important technological and biological insights that have since been applied to the human genome.
The extraordinary progress of the Human Genome Project was made possible by the remarkable international collaboration which developed from the early 1990s. Fostered by the close cooperation of multiple national funding agencies, 20 centres in six countries have worked together (see Appendix), co-ordinating their efforts by sharing technology, resources and information which were freely available throughout the project. Sequencing in many laboratories was also co-ordinated substantially using the genome map itself. This helped to minimize unnecessary duplication and to allow both large and small partners to contribute effectively. The development of new automated sequencing technology, coupled with the adoption of streamlined approaches to generating genome sequence information on a large scale, led to a dramatic acceleration of the programme during the last 2 years, driven by a growing awareness of the enormous value of gaining a first view of the human genome. The result is the emergence of the 'working draft'. Although incomplete, it provides extensive coverage of most of the human genes. The working draft is therefore both an advanced intermediate on the pathway to the production of the finished reference sequence and a product of immediate value in accelerating studies of individual genes, associations with disease and the study of human sequence variation. The working draft is a dynamic product, subject to continual refinement as new data are added. A brief summary of the strategy, milestones and status of the international programme is outlined below, based on current information that is publicly available. A central list of websites providing information is available at (http://www.ncbi.nlm.nih.gov/genome/central; http:// www.ensembl.org/genome/central ). A full analysis is due for publication at the end of 2000.
STRATEGY
An early milestone in tackling the human genome was the construction of a genome-wide genetic linkage map of polymorphic microsatellites, which provided a first framework of 2000 unique landmarks ordered at high odds (>1000:1) across the genome (9) . The use of overlapping YACs (10) and, later, radiation hybrid (RH) mapping (11, 12) resulted in construction of maps of much higher densities of landmarks for each of the human chromosomes (13, (14) (15) (16) (17) (18) (19) (20) . The RH mapping work included another milestone, the human gene map (21) , which was constructed using 30 181 gene-based markers derived from expressed sequence tags (ESTs) (22) selected from nonredundant clusters, or Unigenes (http://www.ncbi.nlm.nih.gov/ Unigene ).
To provide the starting material for sequencing, a complete physical map of overlapping clones was constructed using libraries of large insert (150-250 kb) P1-derived artificial chromosomes (PACs) (23) or BACs (24) . Clones were assembled into contigs on the basis of overlaps identified by pairwise comparison of restriction fingerprints (25, 26) using data generated either by fingerprinting whole genomic libraries or chromosome-specific clone collections. Many overlaps were also identified directly by screening clones with markers from the landmark maps as part of the initial contig assembly process. More recently, large-scale sequencing of BAC clone ends has provided an additional resource to enable new clones to be added to the map directly by matching the BAC end sequences to draft or finished sequences. Additional mapping information on the order, orientation and gap size between contigs has also been established using clones as probes in fluorescence in situ hybridization (FISH) analysis of interphase nuclei or extended DNA fibres. On 15 June 2000, the BAC clone map contained >330 000 clones and comprised 1743 contigs representing an estimated 97-98% of the genome, from which 32 221 clones formed the tile path (or map of accessioned clones) (details are listed at http://genome.wustl.edu/gsc/ ).
To generate the working draft DNA sequence, each BAC or PAC clone in the tile path was subjected to an initial shotgun sequencing phase in which sufficient random reads were assembled into a consensus to provide at least 3-fold coverage of each sequenced base at a quality score [Q value, calculated by the base-calling program PHRED (27, 28) ] of 20 or higher (29) . This provided ∼95% coverage of the insert. At present, each clone is being taken to a full depth shotgun (typically 8-to 10-fold), and this is being followed by a directed 'finishing' phase in which all gaps are closed, ambiguities are resolved, and the entire finished sequence is checked to ensure an accuracy of >99.99% before submission to the public databases (see Appendix, nos 3, 4 and 12).
The availability of draft sequence for every clone in the tile path allows re-calculation of the entire map. Overlaps between all clones can now be based on matching sequences, which provide much more information than the earlier overlap analysis based on fingerprint or landmark data. A set of fragments of accessioned sequence has been merged together for each chromosome and the order and orientation of non-overlapping fragments have been determined where possible using additional information (see http://genome.cse.ucsc.edu/goldenPath). This will continue to be refined as more clone sequences are completed. This dataset enables re-assessment of the order of all landmarks relative to the previous maps, thus providing independent validation of long-range order in the working draft.
The status of the project can be assessed based on the amount of sequence that is available and comparing this figure to the estimated size of the genome. Of course, any estimate is necessarily an approximation, as the true size of the genome is unknown; this will only be determined when all remaining gaps in the genome sequence are measured [for example using the approaches taken when finishing chromosomes 21 and 22 (see below)]. In addition, analysis of the existing sequence is being refined continually to confirm new overlaps, or to define genomic duplications and to make other changes which affect estimates of sequence coverage. The current estimate is that >90% of the euchromatic human genome sequence is publicly available and 23% is finished [as of 31 August 2000: see current progress at (http://www.ncbi.nlm.nih.gov/genome/seq )].
The identification of genes and other important biological features in the sequence requires further analysis. This is carried out on each BAC or PAC as it is released, whether in draft or in finished form. A number of data analysis centres are involved in providing up-to-date annotation of the rapidly evolving draft sequence, generally using fast, automatic analyses. These sites provide consistent annotation and interfaces to the data. The Ensembl database, based at the Sanger Centre and the European Bioinformatics Institute, annotates known genes by aligning mRNA sequence to genomic DNA using the EST_GENOME program. Further genes are detected by predicting candidate gene features, which are then confirmed using homology searches against EST and protein sequence databases (see http://www.ensembl.org ). Analysis of a pre-release of the working draft (24 May 2000, containing 2.2 Gb of sequence data) at Ensembl resulted in detection of 31 000 predicted gene features; extrapolating from this figure to the amount of sequence that is now available, this figure would increase to ∼45 000 genes (see below for discussion of gene number estimates). The National Centre for Biotechnology Information provides a Map Viewer, which displays the available human genome sequence data and includes the location of genes, polymorphisms and other features (http:// www.ncbi.nlm.nih.gov ).
WHOLE GENOME SHOTGUNS
The recent advances in sequencing technology and throughput have led researchers to reconsider the possibility of shotgun sequencing large and complex genomes directly, thus bypassing the mapping stage (30, 31) . The potential advantages of speed and simplicity of the strategy are countered by the difficulties faced in the scale of computing analysis required for assembly of the DNA fragments, plus the many false joins which would inevitably arise from assembly of an entire complex genome sequence containing a range of repetitive sequences (32) . Assembly of 3.2 million reads (12.8 × coverage) of the 120 Mb euchromatic genome of the fruit fly Drosophila melanogaster resulted in an assembly covering 115 Mb of the 120 Mb euchromatic region, with 1630 gaps (33) . Closure of the gaps and correction of the remaining misassemblies are being done using the scaffold of sequenced BAC clones which was also available and had been aligned to the genome sequence (33) . The finishing process is thus modelled on the earlier experience of the nematode genome project.
The experience gained in the D.melanogaster whole genome shotgun assembly was used as a basis for a human whole genome assembly. There are two important differences between the two analyses, however, which would be expected to have a marked effect on the efficiency of the sequence assembly process. First, the human genome contains a diverse collection of repetitive sequences comprising ∼50% of the total. The experience gained in Drosophila is therefore not necessarily representative of the human (or mouse) genomes. Second, the increased size of the human genome (25 times that of the fruit fly) would result in a greatly increased scale of computational analysis. The current availability of a complete working draft of the human genome, assembled on a clone-by-clone basis, however, obviates the need for a whole genome shotgun assembly to be done in isolation. Most of the data from a whole genome shotgun can be aligned with the mapped human sequence that is currently available. The remaining unmatched sequences would be the result of either failures in the matching process, or fragments of human DNA that were represented in the small insert libraries used for the whole genome shotgun, but not represented in the mapped BACs used so far to generate the working draft. Testing of these hypotheses will require access to merged sequence from both projects to enable the appropriate analysis to be carried out.
FINISHING HUMAN CHROMOSOMES
In December 1999, the sequence of the euchromatic part of chromosome 22q (an acrocentric chromosome) was finished (34) and 33.5 Mb was represented in map 10 contigs, of which the largest was 25 Mb. The nine gaps in the clone map (plus one small gap in the sequence, bridged by a clone) covered a total of just over 1 Mb, and the total coverage obtained was therefore 97%. The gaps were not closed after exhaustive screening of BAC and PAC libraries; work is continuing using other cloning systems. At least three of the gaps were deemed unstable in BACs: fibre FISH analysis of several BAC clones showed that each one contained sequence on both sides of a gap but was missing a central portion, which may have been lost during cloning or in subsequent bacterial culture. Chromosome 21, another acrocentric chromosome, was completed 5 months later (35), 33.8 Mb of 21q was represented in just three contigs and the remaining three gaps in the clone map (plus seven small sequence gaps) accounted for only 0.1 Mb. The total coverage was therefore 99.7% of the euchromatin. In addition, 0.28 Mb of the heterochromatic sequence of 21p was also determined.
Both these chromosomes were finished to an accuracy of >99.99%, and annotation of the sequence revealed a marked contrast in gene content. Chromosomes 22 and 21 were found to contain 545 and 225 genes, respectively, plus 134 and 59 pseudogenes, respectively. Differences in base composition and repeat sequence content between the two chromosomes reflected this: the gene-rich chromosome 22 had a higher GC content, more SINEs and slightly fewer LINEs than the genepoor chromosome 21.
HOW MANY GENES IN THE GENOME?
It is important to realize that we will not know the number of genes in the human genome when the genome sequence is finished. Finding all the genes in the genome is dependent on the resolution of methods to analyse the sequence and to identify genes based on characteristic features such as recognizable motifs, homology to other genes, matches to mRNA sequences and ab initio predictions. In many cases, hypothetical gene structures also require experimental validation. With the sequence of the human genome still in draft form, and our knowledge of the repertoire of gene features still limited, estimates of the total number of human genes are necessarily approximate.
An early estimate of 60 000-70 000 human genes was based on the range of different sequences found in a population of ESTs sequenced at random from tissues. A similar figure (80 000) was derived from measuring the total number of CpG islands in the genome, and extrapolating on the basis that 56% of known genes were associated with CpG islands (36). The total gene number based on CpG islands may be an overestimate if some CpG islands are not associated with genes, or if there are cases where more than one CpG island is associated with the same gene.
The availability of much larger EST datasets led to greater divergence in gene number estimates, with the most recent examples ranging from 120 000 (37) to 35 000 (38) . Two problems confound gene number estimates that are based on the complexity of EST collections. First, sampling of ESTs is biased by the tissue sources selected and the depth to which each one is sampled. Therefore, genes which are expressed either at low abundance (i.e. lower than the depth of sampling of the library sequencing), or only in inaccessible tissues or developmental stages, will be under-represented or absent from current datasets. This will lead to an underestimate of the complexity of the EST dataset. Second, EST datasets are composed of incomplete sequences of mRNA and independent ESTs which are derived from the same mRNA may not overlap on the basis of the available sequence data, thus leading to an overestimate of complexity of the EST collection. Ewing and Green. (38) took both these factors into account in their analysis, by using only 3′ EST sequences and by normalizing their results using the annotated sequence of chromosome 22.
Two other analyses have yielded similar estimates. First, the identification of evolutionarily conserved regions ('ecores') between a random set of genomic sequences of the puffer fish Tetraodon nigroviridis and the human genome resulted in estimates of 28 000-34 000 human genes. This study was also normalized with respect to the annotated genes on chromosome 22 (39) . Second, a direct extrapolation from the annotated genes on chromosome 22 alone, or chromosomes 21 and 22 combined (assuming that 35 Mb sequence is 1.1% of the genome) leads to estimates of 43 000 or 34 000 genes, respectively, excluding pseudogenes. These extrapolations assume that either chromosome 22, or the combination of chromosomes 21 and 22, respectively, are representative of the rest of the human genome.
These last estimates are significantly lower than previously assumed views of the number of genes in the human genome. One of the most interesting insights to emerge from comparing complete gene sets in model organisms to date is that gene number is not necessarily a good measure of complexity and this trend may be borne out in the human genome. For example, the fruit fly would be considered more anatomically complex, with 10 times more cells, than the nematode (which has 1000 cells) and the fruit fly also undergoes a more complex developmental process than the nematode worm. Yet the fruit fly genome contains only 13 000 genes, compared with the 19 000 genes found in the nematode genome. Instead, it appears that biological complexity is achieved in other ways. Relatively few gene products may determine relatively complex biochemical and developmental processes. Greater functional complexity and diversity may result from a relatively small number of novel regulatory proteins working in a variety of combinations, for example, and from the existence of multiple protein isoforms.
In practice, the estimates of gene number are most likely to stabilize when the genome sequences of multiple vertebrate genomes are produced and aligned to the human sequence (notably the mouse sequence, for example, is projected to be available within 2 years). This will enable the annotation of genes to be done accurately based on conserved sequences. The location of putative exons can be correlated with functional motifs, such as exon-intron boundaries, and matches to known mRNA and ESTs, and gene structures can be accepted or rejected based on the occurrence of an open reading frame.
GENETIC RECOMBINATION IN THE HUMAN GENOME
The earliest maps of the human genome have relied on the measurement of genetic recombination occurring between two loci in the genome. Genetic linkage maps have provided a view of the order and distance between landmarks (polymorphic loci) that is derived by scoring the number of recombinations observed between two loci in a given number of meioses. For mapping applications, it has generally been assumed that the physical distance (in base pairs) is proportional to the genetic distance (in centiMorgans) between the loci. However, it is well-known that certain regions of the genome exhibit a higher frequency of recombination than others. The frequency of genetic recombination can now be compared with the physical distance between any two markers, given an accurate measurement of the physical distance (or contiguous sequence) between them. This has been demonstrated on chromosome 22, by plotting the genetic distance between microsatellite markers in the genetic map relative to their physical separation along the finished chromosome sequence. The results showed that the frequency of recombination along the chromosome varied (within the limits of resolution of the study) between 1.1 cM/Mb (over most of the chromosome: 28.2 Mb) to 6.2 cM/Mb (averaged over four regions totalling 5.2 Mb) (34). The analysis illustrates how to identify potential recombination hotspots. It may require a much higher resolution of genetic analysis, with many more polymorphic markers (see below), but it is clearly possible to identify minimum regions of genomic sequence which may play a critical role in enhanced recombination and to use knowledge of the sequence to design experimental tests of this hypothesis.
FINDING CONSERVED REGULATORY SEQUENCE ELEMENTS
A wealth of information can be obtained from comparisons between genome sequences, to identify the features which have been conserved during evolution and are therefore likely to be important for survival. Comparisons made between distantly related species (in different phyla) yield information chiefly on gene homologues, as discussed above. Comparison of more closely related species can reveal similarities in gene order (synteny), as seen for example in the extensive synteny over large genomic distances between man and mouse. Great similarity between human and murine sequences is also evident at the sequence level. A recent survey of 77 orthologous mouse and human gene pairs, for example, revealed an average of 82% identity in coding regions (40) , in close agreement to an earlier study comparing cDNA sequences (41) . The gene pair study also illustrated the frequent occurrence of an extensive degree of homology in non-coding regions. Fifty-six per cent of 3′-untranslated regions (UTRs) and 50% of 5′-UTRs had >60% sequence identity. Notably, this level of sequence identity was also observed in the 100 bases immediately upstream of the promoters in 70% of the gene pairs and, over larger blocks, generally conservation was found more often in the upstream sequences (36%) than in introns (23%) (40) .
The systematic identification of conserved sequences in noncoding regions offers potentially an excellent strategy for the identification of transcriptional regulatory elements. The strategy is most applicable to genes that have conserved functions and expression patterns. For example, the stem cell leukaemia (SCL) gene encodes a basic helix-loop-helix transcription factor with a key role in the early stages of haematopoiesis and vasculogenesis (42) . The SCL gene has a specific pattern of expression that is highly conserved in mammals, birds, frogs and teleost fish, indicating that the sequence elements responsible for this level of transcriptional control might also be conserved. This was confirmed following a comparison of the human, mouse and chicken SCL gene sequences, which revealed a series of highly conserved noncoding segments, some of which corresponded precisely with previously characterized SCL enhancers. The analysis also identified a peak of mouse-human-chicken homology, located ∼10 kb downstream of the gene, of no known significance. However, the sequence was found to act as a neural enhancer, directing an appropriate SCL-like pattern of expression of GFP or lacz reporter genes in transgenic frogs and mice, respectively (43) .
CATALOGUING HUMAN SEQUENCE VARIATION
The first human genome sequence provides a reference for characterizing all genes and other features and is applicable to the study of the entire human race. However, there is significant variation between individuals at the level of the DNA sequence. On average, comparison of the sequence of any two genomes results in the detection of a sequence variant every 1000 bases. Most (∼90%) sequence variants are single base substitutions (44, 45) , known as single nucleotide polymorphisms (SNPs), and the remainder are insertions or deletions of one or more bases. Sequence variants that occur within genes or in regulatory elements may affect the function of expression of a gene. These 'functional variants' are responsible for the genetic component of phenotypic variables, including disease susceptibility and drug response. A major goal in human genetics is to identify these functional variants and then to determine how a specific allele contributes to a particular phenotypic characteristic. The association of a phenotype with a particular functional variant allele may be tested directly, by genotyping the variant in an appropriately selected population, or indirectly using a nearby SNP which is in linkage disequilibrium (LD) with the functional variant. The indirect approach, which is likely to predominate this kind of study in the near future, depends on the extent of LD in the human genome. This is unknown and there is likely to be considerable local variation. Estimates based on simulations vary from 3 to 100 kb (46, 47) . Work is in progress in multiple laboratories to obtain a true measure of LD in different regions.
The availability of the working draft has been critical for the development of a first human map of SNPs of sufficient density to allow the ascertainment of LD on a genome-wide basis and to underpin association studies. In addition to locusspecific targeted approaches for SNP finding, which are based on re-sequencing DNA fragments after amplification from different individuals, three genome-wide approaches have been taken. Matching EST sequences to each other (48) , and now to the working draft, allows detection of sequence differences and hence candidate SNPs. Similarly, candidate SNPs have been detected by comparing the draft or finished sequence of overlapping BAC or PAC clones (45; E. Dawson et al., unpublished data), and thus identifying dense clusters of SNPs which are separated by regions of typically 0.1-0.5 Mb. More recently, The SNP Consortium (TSC; a consortium of industrial organizations, the Wellcome Trust and genome research laboratories; see http://www.snp.cshl.org ), have undertaken large-scale genomic sequencing approaches to identify SNPs across the entire genome. Sequences obtained from the DNA of 24 individuals representing a range of ethnic groups were aligned to each other, or to the working draft. Pilot studies carried out either on the whole genome or on chromosome 22 demonstrated the feasibility of the project and, further, that the availability of the genome sequence would more than double the number of candidate SNPs produced (49, 50) . Nearly all the SNPs can also be mapped directly by alignment to the draft sequence and the TSC programme is on course to produce a map at a density of at least one SNP per 5 kb (double the original target) and to finish well ahead of schedule. The integration of SNPs from all sources using the working draft will thus pave the way for a new era in human genetic studies.
CONCLUSION
Sequencing whole genomes has brought many new insights in our understanding of the biology and genetics of the organism. For the first time we are able to compare complete gene sets and to begin to unravel the molecular basis for biological complexity. The sequence of one organism can be used for annotation of another. With the benefit of experience and data from the model organism studies, the emergence of the working draft of the human genome provides an immediate platform to study the biology of Homo sapiens. Already there are great advances being made in resolving the human gene set, establishing studies of their expression in different environments using microarrays and in studying their association with human disease. The value of the working draft is already illustrated from discovery and rapid characterization of many genes involved in disease, notably including genes involved in cancer [the breast cancer gene BRCA2 (51)], immune defects [e.g. X-linked lymphoproliferative disease (52) ], deafness [Pendred syndrome (53) , DFNA5 (54), DFNA13 (55) ] to name but a few. The working draft has also made it possible to construct a comprehensive SNP map of the genome. At the same time, we should not lose sight of the task of finishing the reference sequence. Only then will the full potential of sequence analysis be realized. Armed with a genome sequence that is >99.99% accurate and has no gaps, researchers will be able to explore the functional significance of every last base in the human genome and all the variants thereof, assured of the reliability of their basic reference. Determining the genome sequence has been the main purpose of the Human Genome Project until now; realizing its full potential is the challenge that lies ahead. 
